News & Media


March 1, 2023

Andelyn Biosciences Board of Directors Announce New CEO


March 27, 2023

Andelyn Biosciences Announce New Chief Commercial Officer

(COLUMBUS, Ohio) – Andelyn Biosciences announces the appointment of Matt Niloff as Chief Commercial Officer (CCO). Niloff will lead the...


March 8, 2023

Inspiring the Next Generation of Women in Life Sciences

In honor of International Women's Day, EPM brings you an exclusive roundup of inspiring commentary from over 25 empowering women in the STEM and life sciences industries. These women share their personal experiences of working in these fields, the challenges they face, and their tips for encouraging young women who are wishing to pursue a career in STEM.


February 1, 2023

Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss

Novel AAV Capsid Anc80 enables efficient gene transfer COLUMBUS, OH, 31st JANUARY, 2023 – Andelyn Biosciences, Inc., a pioneering and...


July 11, 2022

Optimizing Process Development Early – A critical factor in successful viral vector scale up and large scale manufacture

John Ketz and Denis Kole speak with Brandy Sargent on The Cell Culture Dish podcast about viral vector production, including current manufacturing challenges, navigating the road to commercialization, and successful scale up strategies.


February 14, 2022

Reliability and the Future of Cell & Gene Therapies

Mayo Pujols, CEO of Andelyn Biosciences, discusses how Cell & Gene companies are focusing on reliability and predictability to further advance this innovative therapy.


November 22, 2021

Nationwide Children’s Spinoff Andelyn Biosciences to Open New Lab in Dublin

Andelyn Biosciences has set its sights on Dublin for one of two new labs for the gene therapy company.


September 30, 2021

Gene therapy manufacturer Andelyn adds lab in Dublin as construction continues in OSU Innovation District

Andelyn Biosciences Inc. is adding a second laboratory in Dublin, and will move into its headquarters in Ohio State University's Innovation District before construction is complete.


September 20, 2016

Nationwide Children’s Hospital Leads Effort for Gene Therapy Treatment for Duchenne Muscular Dystrophy

Sarepta Therapeutics announced yesterday that the FDA has granted accelerated approval for eteplirsen for the treatment of Duchenne muscular dystrophy...

Connect Here With Our Business Team